Allosteric interactions between the antagonist prazosin and amiloride analogs at the human α(1A)-adrenergic receptor

Molecular Pharmacology

Volumn 57, Issue 3, 2000, Pages 436-445

  Leppik, Ray A ^a   Mynett, Anita ^a   Lazareno, Sebastian ^b   Birdsall, Nigel J M ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b Med Res Cncl Collaborative Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 (N ETHYL N ISOPROPYL)AMILORIDE; 5 (N ISOBUTYL N METHYL)AMILORIDE; 5 (N,N DIMETHYL)AMILORIDE; 5 (N,N HEXAMETHYLENE)AMILORIDE; ALPHA 1A ADRENERGIC RECEPTOR; AMILORIDE DERIVATIVE; BENZAMIL; PHENTOLAMINE; PRAZOSIN; TRITIUM;

ALLOSTERISM; ANIMAL CELL; ARTICLE; CHO CELL; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; DISSOCIATION; DRUG BINDING SITE; DRUG RECEPTOR BINDING; DRUG STRUCTURE; MATHEMATICAL MODEL; NONHUMAN; PRIORITY JOURNAL;

EID: 0034100346     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.57.3.436     Document Type: Article

References (24)

1. Birdsall NJM, Farries T, Gharagozloo P, Kobayashi S, Lazareno S and Sugimoto M (1999) Subtype selective positive cooperative interactions between brucine analogues and acetylcholine at muscarinic receptors: Functional studies. Mol Pharmacol 56:778-786.
2. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
3. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
4. Ehlert FJ (1988) Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods. Mol Pharmacol 33:187-194.
5. Ellis J, Huyler J and Brann MR (1991) Allosteric regulation of cloned m1-m5 muscarinic receptor subtypes. Biochem Pharmacol 42:1927-1932.
6. Ellis J and Seidenberg M (1989) Gallamine exerts biphasic allosteric effects at muscarinic receptors. Mol Pharmacol 35:173-176.
7. Ellis J and Seidenberg M (1992) Two allosteric modulators interact at a common site on cardiac muscarinic receptors. Mol Pharmacol 42:638-641.
8. 1-adrenoceptor classification. Br J Pharmacol 121:1127-1135.
9. 1-Adrenoceptor classification: Sharpening Occam's razor. Trends Pharmacol Sci 15:167-170.
10. Galzi J-L and Changeux J-P (1994) Neurotransmitter-gated ion channels as unconventional allosteric proteins. Curr Opin Struct Biol 4:554-565.
11. 2-adrenergic receptors by sodium. J Biol Chem 265:21590-21595.
12. 2-adrenergic receptors. Mol Pharmacol 32:53-58.
13. Hulme EC and Birdsall NJM (1992) Strategies and tactics in receptor-binding studies, in Receptor-Ligand Interactions: A Practical Approach (Hulme EC ed) pp 63-176, IRL Press, Oxford, UK.
14. Lazareno S and Birdsall NJM (1995) Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: Interactions of strychnine and acetylcholine at muscarinic receptors. Mol Pharmacol 48:362-378.
15. Lee NH and El-Fakahany EE (1991) Allosteric antagonists of the muscarinic acetylcholine receptor. Biochem Pharmacol 42:199-205.
16. 2A-adrenergic receptor. Mol Pharmacol 53:916-925.
17. Leppik RA, Miller RC, Eck M and Paquet J-L (1994) Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor. Mol Pharmacol 45:983-990.
18. 1A adrenoceptor. Naunyn-Smiedeberg's Arch Pharmacol 358:604.
19. A receptor channels. Annu Rev Neurosci 17:569-602.
20. + exchange. J Biol Chem 262:12387-12392.
21. Proska J and Tucek S (1995) Competition between positive and negative allosteric effectors on muscarinic receptors. Mol Pharmacol 48:696-702.
22. A receptors. Trends Pharmacol Sci 16:162-168.
23. Waelbroeck M (1994) Identification of drugs competing with d-tubocurarine for an allosteric site on cardiac muscarinic receptors. Mol Pharmacol 46:685-692.
24. 2b-adrenergic receptor subtype. Mol Pharmacol 39:481-486.